Literature DB >> 19237423

Is there an optimum endurance polygenic profile?

Jonatan R Ruiz1, Félix Gómez-Gallego, Catalina Santiago, Marta González-Freire, Zoraida Verde, Carl Foster, Alejandro Lucia.   

Abstract

We analysed seven genetic polymorphisms that are candidates to explain individual variations in human endurance phenotypic traits, at least in Caucasian people (ACE Ins/Del, ACTN3 Arg577Ter, AMPD1 Gln12Ter, CKMM 1170 bp/985 + 185 bp, HFE His63Asp, GDF-8 Lys153Arg and PPARGC1A Gly482Ser) in 46 world-class endurance athletes and 123 controls (all Spanish Caucasians). Using the model developed by Williams & Folland we determined (1) the 'total genotype score' (TGS, from the accumulated combination of the seven polymorphisms, with a maximum value of '100' for the theoretically optimal polygenic score) in the non-athlete (control) group, in the athlete group and in the total Spanish population, and (2) the probability for the occurrence of Spanish individuals with the 'perfect' polygenic endurance profile (i.e. TGS = 100). The probability of a Spanish individual possessing a theoretically optimal polygenic profile for up to the seven candidate genetic polymorphisms we studied was very small, i.e. approximately 0.07% (or 1 in 1351 Spanish individuals). The mean TGS was higher in athletes (70.22 +/- 15.58) than in controls (62.43 +/- 11.45) and also higher than predicted for the total Spanish population (60.80 +/- 12.1), suggesting an overall more 'favourable' polygenic profile in the athlete group. However, only three of the best Spanish endurance athletes (who are also amongst the best in the world) had the best possible score for up to six genes and none of them had the optimal profile. Other polymorphisms yet undiscovered as well as several factors independent of genetic endowment may explain why some individuals reach the upper end of the endurance performance continuum.

Entities:  

Mesh:

Year:  2009        PMID: 19237423      PMCID: PMC2678223          DOI: 10.1113/jphysiol.2008.166645

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  20 in total

1.  The key to top-level endurance running performance: a unique example.

Authors:  Alejandro Lucia; Jesús Oliván; Jerónimo Bravo; Marta Gonzalez-Freire; Carl Foster
Journal:  Br J Sports Med       Date:  2007-11-29       Impact factor: 13.800

2.  Polymorphisms associated with cholesterol and risk of cardiovascular events.

Authors:  Sekar Kathiresan; Olle Melander; Dragi Anevski; Candace Guiducci; Noël P Burtt; Charlotta Roos; Joel N Hirschhorn; Göran Berglund; Bo Hedblad; Leif Groop; David M Altshuler; Christopher Newton-Cheh; Marju Orho-Melander
Journal:  N Engl J Med       Date:  2008-03-20       Impact factor: 91.245

3.  World-class performance in lightweight rowing: is it genetically influenced? A comparison with cyclists, runners and non-athletes.

Authors:  Carlos A Muniesa; Marta González-Freire; Catalina Santiago; José I Lao; Amaya Buxens; Juan C Rubio; Miguel A Martín; Joaquín Arenas; Felix Gomez-Gallego; Alejandro Lucia
Journal:  Br J Sports Med       Date:  2008-09-18       Impact factor: 13.800

Review 4.  Skeletal muscle RAS and exercise performance.

Authors:  Alun Jones; David R Woods
Journal:  Int J Biochem Cell Biol       Date:  2003-06       Impact factor: 5.085

5.  Frequent sequence variation in the human myostatin (GDF8) gene as a marker for analysis of muscle-related phenotypes.

Authors:  R E Ferrell; V Conte; E C Lawrence; S M Roth; J M Hagberg; B F Hurley
Journal:  Genomics       Date:  1999-12-01       Impact factor: 5.736

6.  Polymorphic variation in the human myostatin (GDF-8) gene and association with strength measures in the Women's Health and Aging Study II cohort.

Authors:  M J Seibert; Q L Xue; L P Fried; J D Walston
Journal:  J Am Geriatr Soc       Date:  2001-08       Impact factor: 5.562

7.  The ACTN3 R577X polymorphism in East and West African athletes.

Authors:  Nan Yang; Daniel G MacArthur; Bezabhe Wolde; Vincent O Onywera; Michael K Boit; Sau Yin Mary-Ann Lau; Richard H Wilson; Robert A Scott; Yannis P Pitsiladis; Kathryn North
Journal:  Med Sci Sports Exerc       Date:  2007-11       Impact factor: 5.411

8.  Unique among unique. Is it genetically determined?

Authors:  M Gonzalez-Freire; C Santiago; Z Verde; J I Lao; J Oiivan; F Gómez-Gallego; A Lucia
Journal:  Br J Sports Med       Date:  2008-07-28       Impact factor: 13.800

Review 9.  Epigenetic epidemiology of the developmental origins hypothesis.

Authors:  Robert A Waterland; Karin B Michels
Journal:  Annu Rev Nutr       Date:  2007       Impact factor: 11.848

Review 10.  The human gene map for performance and health-related fitness phenotypes: the 2006-2007 update.

Authors:  Molly S Bray; James M Hagberg; Louis Pérusse; Tuomo Rankinen; Stephen M Roth; Bernd Wolfarth; Claude Bouchard
Journal:  Med Sci Sports Exerc       Date:  2009-01       Impact factor: 5.411

View more
  42 in total

1.  The limits of acceptable biological variation in elite athletes: should sex ambiguity be treated differently from other advantageous genetic traits?

Authors:  J Michael Bostwick; Michael J Joyner
Journal:  Mayo Clin Proc       Date:  2012-06       Impact factor: 7.616

2.  How genes influence life span: the biodemography of human survival.

Authors:  Anatoliy I Yashin; Deqing Wu; Konstantin G Arbeev; Eric Stallard; Kenneth C Land; Svetlana V Ukraintseva
Journal:  Rejuvenation Res       Date:  2012-05-18       Impact factor: 4.663

3.  The -786 T/C polymorphism of the NOS3 gene is associated with elite performance in power sports.

Authors:  Félix Gómez-Gallego; Jonatan R Ruiz; Amaya Buxens; Marta Artieda; David Arteta; Catalina Santiago; Gabriel Rodríguez-Romo; José I Lao; Alejandro Lucia
Journal:  Eur J Appl Physiol       Date:  2009-08-22       Impact factor: 3.078

Review 4.  Genes and elite athletes: a roadmap for future research.

Authors:  Nir Eynon; Jonatan R Ruiz; José Oliveira; José Alberto Duarte; Ruth Birk; Alejandro Lucia
Journal:  J Physiol       Date:  2011-05-03       Impact factor: 5.182

Review 5.  Epigenetics in sports.

Authors:  Tobias Ehlert; Perikles Simon; Dirk A Moser
Journal:  Sports Med       Date:  2013-02       Impact factor: 11.136

6.  ACE I/D, ACTN3 R577X, PPARD T294C and PPARGC1A Gly482Ser polymorphisms and physical fitness in Taiwanese late adolescent girls.

Authors:  Li-Ling Chiu; Tzu-Wen Chen; Sandy S Hsieh; Ling-Ling Hsieh
Journal:  J Physiol Sci       Date:  2012-01-14       Impact factor: 2.781

7.  Genetics and the Elite Athlete: Our Understanding in 2020.

Authors:  Rakesh John; Mandeep Singh Dhillon; Sidak Dhillon
Journal:  Indian J Orthop       Date:  2020-03-11       Impact factor: 1.251

8.  A novel, single algorithm approach to predict acenocoumarol dose based on CYP2C9 and VKORC1 allele variants.

Authors:  Zoraida Verde; Jonatan R Ruiz; Catalina Santiago; Beatriz Valle; Fernando Bandrés; Elpidio Calvo; Alejandro Lucía; Félix Gómez Gallego
Journal:  PLoS One       Date:  2010-06-18       Impact factor: 3.240

Review 9.  Genes for elite power and sprint performance: ACTN3 leads the way.

Authors:  Nir Eynon; Erik D Hanson; Alejandro Lucia; Peter J Houweling; Fleur Garton; Kathryn N North; David J Bishop
Journal:  Sports Med       Date:  2013-09       Impact factor: 11.136

10.  The combined impact of metabolic gene polymorphisms on elite endurance athlete status and related phenotypes.

Authors:  Ildus I Ahmetov; Alun G Williams; Daniil V Popov; Ekaterina V Lyubaeva; Albina M Hakimullina; Olga N Fedotovskaya; Irina A Mozhayskaya; Olga L Vinogradova; Irina V Astratenkova; Hugh E Montgomery; Viktor A Rogozkin
Journal:  Hum Genet       Date:  2009-12       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.